🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Comparison of NOM for ACLD Between Medical and Surgical Ward

Recruitingn/aAges 18 Years - anyAllOspedali Riuniti Trieste
NCT06265649 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

In Europe, patients with acute left colon diverticulitis (ALCD) are usually admitted to surgical wards even when only medical treatment is required. The study compares ALCD non-operative management (NOM) between surgical and non-surgical environments regarding clinical outcomes, hospitalization length(LOS), and follow-up.

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients affected by ALCD using a contrast-enhanced CT scan at admission undergoing NOM Exclusion Criteria: * immediate indication for surgery (i.e. patients with Hinchey III or IV ALCD or septic patients with Hinchey II)
💊

What it tests

  • NOM
📍

Where

1 site
Manuela Mastronardi
Trieste, Italy
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy